Encompass Health (NYSE: EHC) director credited 19 RSUs tied to $0.19 dividend

Q: What did Kevin J. O'Connor report on his Form 4 for Encompass Health (EHC)?

Kevin J. O'Connor reported an automatic grant of 19 RSUs tied to Encompass Health common stock. The award was credited on July 15, 2026 under existing restricted stock unit agreements in connection with a common stock dividend payment.

Q: Was Kevin J. O'Connor’s Encompass Health (EHC) Form 4 a market purchase or sale?

The Form 4 shows no open-market purchase or sale . It reports a grant/award acquisition of 19 RSUs at $0.00 per share , credited automatically under restricted stock unit agreements related to a dividend payment.

Q: How were the RSUs for Kevin J. O'Connor’s Encompass Health (EHC) award calculated?

The RSUs are credited based on a formula using RSUs held on the dividend record date , the $0.19 per-share dividend , and the $109.88 closing price on the dividend payment date. The resulting award for this dividend was 19 RSUs .

Q: What dividend and stock price are associated with Kevin J. O'Connor’s Encompass Health (EHC) RSU award?

On July 15, 2026, Encompass Health paid a $0.19 per-share dividend on its common stock, and the stock’s closing price was $109.88 . These figures were used to credit 19 RSUs to Kevin J. O'Connor’s director account.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Encompass Health Corp director Kevin J. O'Connor reported an automatic grant/award acquisition of 19 Encompass Health Common Stock-equivalent RSUs on July 15, 2026, at $0.00 per share. These RSUs were credited under existing restricted stock unit agreements in connection with a $0.19 per-share dividend, when the stock closed at $109.88. Following this award, O'Connor directly holds 11,582 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider O'Connor Kevin J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	19	$0.00	--

Holdings After Transaction: Encompass Health Common Stock — 11,582 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

RSUs awarded: 19.0000 units Transaction price per share: $0.0000 per share Shares owned after transaction: 11,582.0000 shares +2 more

5 metrics

RSUs awarded 19.0000 units Grant/award acquisition on July 15, 2026 tied to dividend

Transaction price per share $0.0000 per share Price for the 19-unit RSU award

Shares owned after transaction 11,582.0000 shares Direct holdings of Kevin J. O'Connor following the RSU award

Dividend per share $0.19 per share Common stock dividend paid on July 15, 2026

Closing stock price $109.88 per share Encompass Health closing price on the July 15, 2026 dividend payment date

Key Terms

restricted stock units ("RSUs"), dividend record date, dividend payment date

3 terms

restricted stock units ("RSUs") financial

"additional restricted stock units ("RSUs") are credited to each non-employee director's account"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

dividend record date financial

"number of the RSUs in each director's account on the associated dividend record date"

dividend payment date financial

"divided by (b) the closing price on the dividend payment date"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/16/2026 - 04:15 PM Accepted by SEC EDGAR 07/16/2026 - 04:15 PM

FAQ

What did Kevin J. O'Connor report on his Form 4 for Encompass Health (EHC)?

Kevin J. O'Connor reported an automatic grant of 19 RSUs tied to Encompass Health common stock. The award was credited on July 15, 2026 under existing restricted stock unit agreements in connection with a common stock dividend payment.

How many shares or units does Kevin J. O'Connor hold in Encompass Health (EHC) after this Form 4 transaction?

After the reported transaction, Kevin J. O'Connor directly holds 11,582 shares of Encompass Health Common Stock. This total reflects his position following the 19-unit RSU award credited on July 15, 2026.

Was Kevin J. O'Connor’s Encompass Health (EHC) Form 4 a market purchase or sale?

The Form 4 shows no open-market purchase or sale. It reports a grant/award acquisition of 19 RSUs at $0.00 per share, credited automatically under restricted stock unit agreements related to a dividend payment.

How were the RSUs for Kevin J. O'Connor’s Encompass Health (EHC) award calculated?

The RSUs are credited based on a formula using RSUs held on the dividend record date, the $0.19 per-share dividend, and the $109.88 closing price on the dividend payment date. The resulting award for this dividend was 19 RSUs.

What dividend and stock price are associated with Kevin J. O'Connor’s Encompass Health (EHC) RSU award?

On July 15, 2026, Encompass Health paid a $0.19 per-share dividend on its common stock, and the stock’s closing price was $109.88. These figures were used to credit 19 RSUs to Kevin J. O'Connor’s director account.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Connor Kevin J.

(Last)

(First)

(Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM

ALABAMA

35242

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Encompass Health Common Stock	07/15/2026		A		19⁽¹⁾	A	$0	11,582	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Kevin J. O'Connor	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR